piercingiewinsight for sharp investors

· Health Care Equipment · S&P 500

HOLX HOLOGIC INC

Taken private Apr 2026 — last public read

9 of 15

Reach, Weight, and Proof.

3Reach
3Weight
3Proof

Last updated score 31 AugLast review 31 AugLast earnings call —Next earnings call not posted yet

What they are doing

Blackstone and TPG completed the take-private on 7 Apr 2026. This is a last public read, not an equity idea. FY2025 10-K: Genius Digital Diagnostics with the Genius Cervical AI Algorithm (FDA De Novo DEN210035, Jan 2024), Genius AI Detection 2.0 (K243341, Jul 2025), and 3DQuorum (claimed ~1 hour saved per 8 hours of reading — a labeled spec, not a 2026 operating KPI). Last 10-Q is Dec 2025; no Q2 2026 call. Do not put this on the interesting-ones list as a position.

Why the score

  • Reach 3 not 4: cervical cytology + breast CAD / 3DQuorum. Not the whole chain.
  • Weight 3 not 4: AI is in the diagnostic offer. Still a hardware / assay company.
  • Proof 3 not 4: FDA-cleared, named in the 10-K. No current public KPI.

What would move it next quarter: Off the public list. Keep the score as a last print only.

Open these first

Evidence

HOLX 10-K (2025-11-18)

Genius Digital Diagnostics with the Genius Cervical AI Algorithm: first CE-marked and FDA-cleared digital cytology platform. Genius AI Detection, including PRO. 3DQuorum: AI-powered algorithm that reduces 3D images to review by two-thirds, saving an estimated average of one hour per eight hours of daily image interpretation — labeled spec, not a 2026 operating series.

HOLX 10-Q (period ended 27 Dec 2025)

Last public 10-Q. Repeats 10-K AI product language. No new algorithm KPI. No later 10-Q — company private 7 Apr 2026.

Take-private (7 Apr 2026)

Blackstone and TPG completed the acquisition. Nasdaq listing ended 7 Apr 2026.